Vascular characterisation of triple negative breast carcinomas using dynamic MRI

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Radiology

• Publication date

  2011-01-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00330-011-2061-2PMID 21258931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Triple-negative breast cancer: correlation between imaging and pathological findings

  2010cited by this paper
• Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research.

  2010cited by this paper
• Triple-negative breast cancer.

  2010cited by this paper
• Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.

  2010cited by this paper
• Triple-Negative Breast Cancer: Role of Antiangiogenic Agents

  2010cited by this paper
• Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer

  2010cited by this paper
• Triple negative breast cancers: clinical and prognostic implications.

  2009cited by this paper
• Triple-negative breast cancer: correlation between MR imaging and pathologic findings.

  2009cited by this paper
• Triple-negative breast cancer--current status and future directions.

  2009cited by this paper
• Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.

  2009cited by this paper
• Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

  2009cited by this paper
• Triple‐negative/basal‐like breast cancer: review

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Comparison of Subgroup Analyses of PFS from Three Phase III Studies of Bevacizumab in Combination with Chemotherapy in Patients with HER2-Negative Metastatic Breast Cancer (MBC).

  2009cited by this paper
• Clinical Benefit Rate and Time to Response in RIBBON-1, a Randomized, Double-Blind, Phase III Trial of Chemotherapy with or without Bevacizumab (B) for the First-Line Treatment of HER2-Negative Locally Recurrent or Metastatic Breast Cancer (MBC).

  2009cited by this paper
• Comparison of triple‐negative and estrogen receptor‐positive/progesterone receptor‐positive/HER2‐negative breast carcinoma using quantitative fluorine‐18 fluorodeoxyglucose/positron emission tomography imaging parameters

  2008cited by this paper
• Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome

  2008cited by this paper
• What is triple-negative breast cancer?

  2008influential reference
• Warburg revisited: imaging tumour blood flow and metabolism

  2008cited by this paper
• Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer

  2008cited by this paper
• Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO.

  2008cited by this paper
• Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.

  2007influential reference
• Triple-negative breast cancer: MRI features in 29 patients.

  2007cited by this paper
• Basic FGF augments hypoxia induced HIF‐1‐alpha expression and VEGF release in T47D breast cancer cells

  2007cited by this paper
• Reproducibility of reference tissue quantification of dynamic contrast-enhanced data: comparison with a fixed vascular input function

  2007cited by this paper
• Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response

  2007cited by this paper
• Are triple-negative tumours and basal-like breast cancer synonymous?

  2007cited by this paper
• Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data.

  2006cited by this paper
• Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

  2006cited by this paper
• Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis

  2006cited by this paper
• Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

  2006cited by this paper
• Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges.

  2004cited by this paper
• Dynamic magnetic resonance imaging of tumor perfusion

  2004cited by this paper
• The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer

  2004cited by this paper
• Microenvironmental and cellular consequences of altered blood flow in tumours.

  2003cited by this paper
• Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis

  2002influential reference
• The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.

  2001cited by this paper
• High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

  1999cited by this paper
• Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics

  1997influential reference
• Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging

  1996cited by this paper
• Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model

  1995cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Role of Ultrafast Dynamic Contrast-Enhanced MRI in Breast Cancer Prognostication: Correlation Between Early Kinetic Parameters and Tumor Aggressiveness and Histopathologic Characteristics

  2025cites this paper
• Personalized prediction of pathological complete response in breast cancer neoadjuvant therapy: a nomogram combining quantitative MRI biomarkers and molecular subtypes

  2025cites this paper
• T1 Mapping-Derived Parameters in Breast Lesions: Diagnostic Accuracy and Correlation with Pathologic Features.

  2025cites this paper
• Combination of IVIM with DCE-MRI for diagnostic and prognostic evaluation of breast cancer.

  2024cites this paper
• A Deep Learning Model for Predicting Molecular Subtype of Breast Cancer by Fusing Multiple Sequences of DCE-MRI From Two Institutes.

  2024cites this paper
• Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer

  2024cites this paper
• Affinity of PET-MRI Tracers for Hypoxic Cells in Breast Cancer: A Systematic Review

  2024cites this paper
• Expression of HIF-1α and markers of angiogenesis and metabolic adaptation in molecular subtypes of breast cancer

  2023cites this paper
• A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI

  2023influential citation
• Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers

  2022cites this paper
• A Simultaneous Multiparametric 18F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer

  2022cites this paper
• Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review

  2022cites this paper
• Analysis of Volumetric Perfusion Quantitative Parameters Using CS-VIBE Breast Dynamic Contrast Enhanced MR Imaging.

  2022cites this paper
• Identification of the Benignity and Malignancy of BI-RADS 4 Breast Lesions Based on a Combined Quantitative Model of Dynamic Contrast-Enhanced MRI and Intravoxel Incoherent Motion

  2022cites this paper
• Correlation of magnetic resonance imaging quantitative parameters and apparent diffusion coefficient value with pathological breast cancer

  2022cites this paper
• Quantitative parameters of magnetic resonance imaging cannot predict human epidermal growth factor receptor 2 (HER2) status in rectal cancer.

  2021cites this paper
• Correlation of DCE-MRI Perfusion Parameters and Molecular Biology of Breast Infiltrating Ductal Carcinoma

  2021cites this paper
• A multi-compartment model for intratumor tissue-specific analysis of DCE-MRI using non-negative matrix factorization.

  2021cites this paper
• Soft tissue sarcoma: can dynamic contrast-enhanced (DCE) MRI be used to predict the histological grade?

  2020cites this paper
• Applications of Quantitative Perfusion and Permeability in the Body

  2020cites this paper
• Assessing the accuracy of conventional gadolinium‐enhanced breast MRI in measuring the nodal response to neoadjuvant chemotherapy (NAC) in breast cancer

  2020cites this paper
• Evaluation of quantitative dynamic contrast‐enhanced (DCE)‐MRI parameters using a reference region model in invasive ductal carcinoma (IDC) patients

  2020cites this paper
• Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging

  2020cites this paper
• Evaluating the Relationship Between Dynamic Contrast‐Enhanced MRI (DCE‐MRI) Parameters and Pathological Characteristics in Breast Cancer

  2020cites this paper
• The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them

  2020cites this paper
• Identification of long non-coding RNA-mediated transcriptional dysregulation triplets reveals global patterns and prognostic biomarkers for ER+/PR+, HER2− and triple negative breast cancer

  2019cites this paper
• A pilot study of low-dose CT perfusion imaging (LDCTPI) technology in patients with triple-negative breast cancer

  2019cites this paper
• Morphological and Semiquantitative Kinetic Analysis on Dynamic Contrast Enhanced MRI in Triple Negative Breast Cancer Patients.

  2019cites this paper
• Kinetic volume analysis on dynamic Contrast-enhanced MRI of Triple-Negative breast cancer: Associations with survival outcomes.

  2019cites this paper
• Radiomique de l’imagerie par résonnance magnétique (IRM) multiparamétrique pour la prédiction de la réponse pathologique complète chez les femmes traitées par chimiothérapie néoadjuvante d’un cancer du sein triple négatif

  2019cites this paper
• Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy

  2018cites this paper
• Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC).

  2018cites this paper
• Development of a Non-invasive Assessment of Hypoxia and Neovascularization with Magnetic Resonance Imaging in Benign and Malignant Breast Tumors: Initial Results

  2018cites this paper
• Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer

  2018cites this paper
• Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions

  2018cites this paper
• Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status

  2018cites this paper
• Use of diffusion kurtosis imaging and quantitative dynamic contrast‐enhanced MRI for the differentiation of breast tumors

  2018cites this paper
• Light-Activated Core-Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer.

  2018cites this paper
• Prediction of low-risk breast cancer using quantitative DCE-MRI and its pathological basis

  2017cites this paper
• Contrast agents in dynamic contrast-enhanced magnetic resonance imaging

  2017cites this paper
• Análisis de los factores radio-patológicos y terapéuticos del cáncer de mama triple negativo y su influencia en la recidiva y supervivencia libre de enfermedad

  2017cites this paper
• DCE‐ and DW‐MRI as early imaging biomarkers of treatment response in a preclinical model of triple negative breast cancer

  2017cites this paper
• [Association of parameters in dynamic contrast-enhanced MRI using reference region model with prognostic factors and molecular subtypes of breast cancer].

  2017cites this paper
• Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype

  2017cites this paper
• Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy

  2016cites this paper
• Prediction of low-risk breast cancer using perfusion parameters and apparent diffusion coefficient.

  2016influential citation
• Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL

  2016influential citation
• Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis

  2016cites this paper
• Triple-negative breast carcinoma: heterogeneity in immunophenotypes and pharmacokinetic behavior.

  2016cites this paper
• Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size

  2016cites this paper
• Triple-negative breast carcinoma: heterogeneity in immunophenotypes and pharmacokinetic behavior.

  2016cites this paper
• Carcinoma de mama triple negativo. Heterogeneidad inmunofenotípica y en el comportamiento farmacocinético

  2016cites this paper
• MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes

  2015cites this paper
• Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.

  2015cites this paper
• Pharmacokinetics of Gd(DO3A-Lys) and MR imaging studies in an orthotopic U87MG glioma tumor model.

  2015cites this paper
• Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?

  2015cites this paper
• IRM de perfusion et TEP-TDM avant chimiothérapie néoadjuvante pour prédire la réponse histologique des cancers du sein

  2015cites this paper
• Tumor Angiogenesis for Radiologist Part 2: Clinical Utility

  2015cites this paper
• Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy

  2015cites this paper
• Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.

  2015cites this paper
• Imaging of Tumor Angiogenesis for Radiologists--Part 2: Clinical Utility.

  2015cites this paper
• Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging

  2015cites this paper
• Research and progress in magnetic resonance imaging of triple-negative breast cancer.

  2014cites this paper
• Dynamic contrast enhanced‐MRI in rectal cancer: Inter‐ and intraobserver reproducibility and the effect of slice selection on pharmacokinetic analysis

  2014cites this paper
• Le cancer du sein triple-négatif. Le triple-négatif est fréquent chez les patientes mutées : comment ne pas le rater ? Comment le caractériser ? De manière plus générale, l’imagerie peut-elle orienter vers le diagnostic histologique ? ☆

  2014cites this paper
• Triple negative breast cancer: MRI features in comparison to other breast cancer subtypes with correlation to prognostic pathologic factors

  2014cites this paper
• Correlations Between Molecular Subtypes and Pathologic Response Patterns of Breast Cancers After Neoadjuvant Chemotherapy

  2014cites this paper
• Is there any correlation between model-based perfusion parameters and model-free parameters of time-signal intensity curve on dynamic contrast enhanced MRI in breast cancer patients?

  2014cites this paper
• Diffusion‐weighted imaging of the high‐risk breast: Apparent diffusion coefficient values and their relationship to breast density

  2014cites this paper
• Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients

  2014cites this paper
• Associations between tumor vascularization assessed by in vivo DCE‐MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis

  2014cites this paper
• Amide proton transfer imaging of the breast at 3 T: Establishing reproducibility and possible feasibility assessing chemotherapy response

  2013cites this paper
• Diagnostic Value of Contrast-Enhanced Ultrasound Parametric Imaging in Breast Tumors

  2013cites this paper
• Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers.

  2013cites this paper
• Perfusion studies in senology.

  2013cites this paper
• Étude de la perfusion en sénologie

  2013cites this paper
• Breast Cancer Molecular Phenotype and the Use of HER2-Targeted Agents Influence the Accuracy of Breast MRI After Neoadjuvant Chemotherapy

  2013cites this paper
• Imaging of triple-negative breast cancer.

  2012cites this paper
• Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes

  2012influential citation
• Radiological features of triple-negative breast cancers (73 cases).

  2012cites this paper
• Aspects radiologiques des cancers du sein triple négatifs : à propos de 73 cas

  2012cites this paper
• Radiological features of triple-negative breast cancers ( 73 cases )

  2012cites this paper
• spects radiologiques des cancers du sein triple égatifs : à propos de 73 cas

  2012cites this paper
• Correlation of perfusion parameters on dynamic contrast‐enhanced MRI with prognostic factors and subtypes of breast cancers

  2012cites this paper
• Aspects radiologiques des cancers du sein triple négatifs : à propos de 73 cas

  2012cites this paper
• Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study

  2011cites this paper
• Radiological diagnostics of triple negative breast cancer: a review

  2011cites this paper